Search results
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 7 days agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 4 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 6 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 4 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing...
Benzinga· 2 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 6 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 7 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...